What this shows
Market trades first
This view focuses on purchases and sales with reported trade value. Lower-signal rows are moved out of the first screen, not hidden.
Ticker page
MANE Insider Trading Activity
Track Veradermics, Incorporated (MANE) insider transactions, SEC Form 4 filings, insider buys, insider sales, filing dates, trade values, and source links. Recent summary: 74 trades, 18 buys, and 0 sales. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View MANE
Access Free feed
Quick read What does this view show?
Why it matters
Use it as the default scan
Start here when you want the newest activity that most retail investors expect from an insider trading feed.
How to read it
Open the full ledger when needed
Use All Form 4 Filings when you want grants, exercises, gifts, conversions, and every normalized row.
Stacked feeds
Key insider views at a glance
Filings
MANE Form 4 filing history
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning.
| Ticker | Type & Role | Value | Filed |
|---|---|---|---|
Cluster Buy Director | $5M | ||
Cluster Buy Director | $58.9K | ||
Cluster Buy Director | $63.7K | ||
Cluster Buy Director | $91.4K | ||
Cluster Buy Director | $58.9K | ||
Free weekly recapGet the easiest version of the insider feed in your inbox. | |||
Cluster Buy Director | $63.7K | ||
Cluster Buy Director | $91.4K | ||
Cluster Buy Director | $58.9K | ||
Cluster Buy Director | $63.7K | ||
Cluster Buy Director | $91.4K | ||
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Latest news
MANE headlines
- MANE Study 302: Veradermics Posts Positive Top-Line Phase II/III Results for Oral Minoxidil Pill · May 3, 2026
- Veradermics (MANE) Reports Positive Phase 2/3 Results for Male Pattern Hair Loss Treatment VDPHL01 · Apr 30, 2026
- Newly Listed Veradermics Hair Loss Drug Shows Hair Growth Gains · Apr 29, 2026
- Midday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC · Apr 28, 2026
- Biotech Skyrockets Nearly 50% On A Potential Game-Changer In Hair Loss · Apr 27, 2026
Plain-English summary
MANE insider activity summary
Veradermics, Incorporated (MANE) insider activity over the recent reporting window includes 18 insider purchases totaling approximately $18.7M. Market data shows a current price of $114.80 and a market capitalization of $4.76B. Blue Collar Picks normalizes public SEC Form 4 filings into a research-friendly view organized by ticker, insider role, transaction type, filing date, and reported value. MANE pages are designed as a research starting point, not investment advice. Verify the original SEC filing, read the transaction code, compare the trade against the insider's role and history, and consider whether the activity is an open-market purchase, a sale, a grant, an option exercise, or another lower-signal filing type before drawing conclusions.
Company snapshot
Veradermics, Incorporated at a glance
Context
Earnings & analyst view
Earnings
May 15, 2026
Analyst View
$126.00 +9.76% upside
Target range $120.00–$138.00.
Cluster activity
Recent insider clusters for MANE
Filings where three or more insiders bought MANE shares within a short window. Each link opens the cluster page with the full member breakdown.
Ownership context
Top institutional holders
| Holder | Shares | % Held | Value | Reported |
|---|---|---|---|---|
| Aberdeen Group plc | 1,054,660 | 0.03% | $121.1M | Mar 31, 2026 |
| Emerald Advisers, LLC | 132,536 | 0.00% | $15.2M | Mar 31, 2026 |
| Emerald Mutual Fund Advisers Trust | 109,283 | 0.00% | $12.5M | Mar 31, 2026 |
| Private Advisor Group, LLC | 5,000 | 0.00% | $574K | Mar 31, 2026 |
| NVWM, LLC | 35 | — | $4K | Mar 31, 2026 |
Primary source
Verify with the original SEC filings
Blue Collar Picks normalizes public Form 4 records but the SEC filing is the source of record. Use the original filing before making any investment decision.
Open MANE Form 4 filings on SEC EDGAR → See insider trading stocks ranked by activity → Read the Blue Collar Picks methodology → Read the investment disclaimer →
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method
Public data, presented plainly
Named views
Ready-made views give you a clear starting point before you touch filters.
Cluster logic
Cluster buys mean multiple insiders buying the same ticker inside a short window.
Normalized rows
Rows preserve filing date, trade date, role, value, and source links where available.
All data remains available
Filtered rows are not hidden. Grants, exercises, tax withholding, gifts, and conversions stay available in All Form 4 Filings, ticker history, and specialized views.
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.